Physician profile

Gary H Emerson

Obstetrics & Gynecology · Florence, SC

NPI 1770556169

$4,102.73

in general payments reported to CMS, 2019-2025

47 companies · $672 in 2025

The $672 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,786.87
Education$184.98

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $869.31 2019-2024
Astellas Pharma US INC $311.28 2019-2025 Veozah, Myrbetriq
Sage Therapeutics, LLC $237.22 2024-2025 Zurzuvae
Organon LLC $209.87 2021-2024 Nexplanon
Daiichi Sankyo INC. $191.00 2019-2024 Injectafer
Aspira Women'S Health INC $176.65 2021-2024 Ova1
Hologic Sales and Service, LLC $171.60 2023-2025 Thinprep 2000 Processor, Aptima, Fluent Fluid Management System
Bayer Healthcare Pharmaceuticals INC. $133.55 2019-2025
Avion Pharmaceuticals $117.38 2019-2021
Scynexis, INC. $104.01 2022
Exeltis, USA INC. $103.10 2021-2025 Slynd
Pfizer INC. $95.44 2019-2025
Therapeuticsmd, INC. $93.97 2019-2022
Meditrina $92.60 2023-2024
Intuitive Surgical, INC. $90.00 2024-2025
Show all 47 companies
CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $88.40 2021-2024 Wegovy, Saxenda
Takeda Pharmaceuticals U.S.A., INC. $74.39 2019-2021
Mylan Pharmaceuticals INC. $70.37 2021-2022
Minerva Surgical, INC $60.23 2023-2024
Merck Sharp & Dohme LLC $59.47 2019-2020
Innovation Technologies INC $59.42 2024-2025 Irrisept
Sumitomo Pharma America, INC. $56.34 2025 Myfembree, Gemtesa
Shield Therapeutics INC $55.31 2023 Accrufer
Optumhealth Care Solutions, LLC $53.67 2024-2025 Eitan Medical, Vivify Health Care Team Portal 001
Vertex Pharmaceuticals Incorporated $44.94 2024-2025
Agile Therapeutics, INC. $39.03 2021-2022
Amag Pharmaceuticals, INC. $39.02 2019-2020
Hydrofera LLC $38.56 2025 Cutimed Sorbion
Lupin INC. $36.16 2019-2020
Mayne Pharma Commercial LLC $34.70 2022
Amgen INC. $29.25 2019-2020
Octapharma USA, INC. $29.08 2025 Fibryga
Virtus Pharmaceuticals LLC $26.89 2021
Supernus Pharmaceuticals, INC. $21.16 2025 Qelbree
Coopersurgical, INC. $19.69 2024 Paragard T 380a
Solventum Corporation $19.66 2024 Prevena
Alexion Pharmaceuticals, INC. $19.00 2019
Sanofi-Aventis U.S. LLC $16.90 2024
Sanara Medtech INC. $15.07 2025 Celleraterx
Axsome Therapeutics, INC. $13.92 2025 Auvelity
Medicem INC. $13.85 2022
Ethicon US, LLC $13.16 2019
Evofem Biosciences, INC. $12.93 2021
Boston Scientific Corporation $12.71 2023 Advantage System
Horizon Therapeutics Plc $12.67 2020
Covidien LP $12.67 2019
Channel Medsystems, INC. $7.13 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gary H Emerson

$4,102.73

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $672 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/80012/gary-h-emerson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.